DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Health2047 Capital Partners Management, LLC
Health2047 Capital Partners Management, LLC
Funding the future of healthcare.
venture manager, reported GAV $68M across 1 vehicles
Importance
19
moderate
Active deployment
30
moderate
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
- Headquarters
- Reno, NVadviserinfo.sec.gov
- Office address
- 6523 CHAMPETRE COURT, Reno, NV, 89511adviserinfo.sec.gov
- Business phone
- 650-546-7145adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- May 5, 2026
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $52.4Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- enquiries@health2047capital.comhealth2047capital.compublished by the subject
- business email
- investors@health2047capital.comhealth2047capital.compublished by the subject
- business email
- startups@health2047capital.comhealth2047capital.compublished by the subject
- business phone
- 650-546-7145adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
10 observed deals
Stated (the firm’s website)
- Sectors
- ai, fintech, healthcare, consumer
- Stages
- not stated or not yet read
- Geography
- united states
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 90%Hospitals and Physicians 10%
lead rate n/afollow-on rate n/anew logos, 12 months 10
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Health2047 Capital Partners Fund I, L.P. | Fund | 2018 form d first sale | Harvest | $68.2M Mar 8, 2024 | 28 | $46.6M of $250M | Oct 20, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
6 current, 3 departed
Lisa Danzig
Board or advisoryAdvisor
Douglass Given
Managing partnerManaging Partner
Douglass Bruce Given
PartnerMember · since Apr 1, 2018
Gary Cookhorn
PartnerPartner
Ray Bingham
PartnerPartner
3 departed (kept with end dates)
- Joseph Allen Boystak · Member · Apr 1, 2018 to Mar 13, 2020 Inference
- Thomas Richardson Frederick · Member · Apr 1, 2018 to Mar 13, 2020 Inference
- Gary Lloyd Cookhorn · Chief Financial Officer · Apr 1, 2018 to Mar 23, 2021 Inference
Investments on record
10 edges, 10 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
Lifeforce Capital Management, LLC 2 shared · recurringSocium Ventures 1 shared · one timeEpsilon Health Investors, LLC 1 shared · one timeAmboy Street Ventures, LLC 1 shared · one timeActivant Capital Group LLC 1 shared · one timeAlumni Ventures 1 shared · one time · they led 1Gaingels 1 shared · one timeXYZ Venture Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
6 dated events
- Mar 23, 2021Gary Lloyd Cookhorn (Chief Financial Officer) no longer on Schedule A of Health2047 Capital Partners Management, LLC
- Mar 13, 2020Joseph Allen Boystak (Member) no longer on Schedule A of Health2047 Capital Partners Management, LLC
- Mar 13, 2020Thomas Richardson Frederick (Member) no longer on Schedule A of Health2047 Capital Partners Management, LLC
- Jun 7, 2018Health2047 Capital Partners Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 7, 2018Health2047 Capital Partners Fund I, L.P. first reported on Form ADV by Health2047 Capital Partners Management, LLC (Venture Capital Fund), GAV $30,303,030Fund first reported on Form ADVFundsFactHealth2047 Capital Partners Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 1, 2018Gary Lloyd Cookhorn joined Schedule A of Health2047 Capital Partners Management, LLC as Chief Financial Officer
Classification history
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $68M across 1 vehicles
Evidence
49 observations from 3 sources